Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

Abstract

The responses observed in this phase I clinical trial are significant and of long duration. Most of the responders were in treatment groups infused with DC pulsed with PSM-P1 or -P2, suggesting the requirement of both components for effective immunotherapy.

References

Page 1

	Year	Citations
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. Catia Traversari, Pierre van der Bruggen, Immanuel F. Luescher, The Journal of Experimental Medicine HlaHistocompatibilityHla ImmunogeneticsImmunologyPathology	1992	694
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. George E. Peoples, Peter S. Goedegebuure, Robert W. Smith, Proceedings of the National Academy of Sciences HistocompatibilityBreast OncologyImmunologyGynecologyAntigen Processing	1995	440
Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine Donald L. Morton, Leland J. Foshag, Dave S.�B. Hoon, Annals of Surgery	1992	404
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen G.P. Murphy, B.A. Tjoa, Haakon Ragde, The Prostate	1996	395
Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28 Peter Parham, Frances M. Brodsky Human Immunology HistocompatibilityHlaCytotoxic Monoclonal AntibodyAutoimmune DiseaseHuman Leukocyte Antigen	1981	320
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. Jones Gw, Curtis Mettlin, Murphy Gp, PubMed	1995	80
Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients. G.P. Murphy, Haakon Ragde, Gerald M. Kenny, PubMed Prostatic Cancer PatientsUrologyUrological ResearchGenitourinary CancerMedicine	1995	70
In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy B.A. Tjoa, Sheila J. Erickson, Robert J. Barren, The Prostate	1995	51
Cytotoxic T‐Cell Clones Isolated from Ovarian Tumour Infiltrating Lymphocytes Recognize Common Determinants on Non‐Ovarian Tumour Clones Constantin G. Ioannides, Bryan Fisk, M S Pollack, Scandinavian Journal of Immunology	1993	32

Page 1